THE ANABOLICPROTOCOL
MedicationsMedium risk

Enclomiphene

Also known as: Enclomifen, Enclomiphene Citrate, Androxal, trans-Clomiphene, Enclo

The pure active isomer of clomiphene — raises the body's own testosterone via LH and FSH, without the isomer responsible for most of clomiphene's side effects.

Substance family

SERMs

Selective estrogen receptor modulators. They block the receptor in some tissues while leaving it active in others — which is why they restart the hormonal axis and protect breast tissue without lowering estradiol itself.

Effects on

Which outcomes this substance acts on — descriptive, not a recommendation.

Strain profile

Where this substance is most likely to hit — a rough orientation, individually dependent on dose, duration and predisposition.

Liver
low
Kidneys
minimal
Blood lipids
low
Hematocrit
low
Blood pressure
minimal
Hormonal axis
medium

This substance works against

Dosing & protocols by goal

Rough orientation ranges as reported in harm-reduction literature — not an individual treatment plan. Doses are individual and open-ended; frequency depends on the ester or half-life.

Restarting the axis (post-cycle)

Advanced

Dose

12.5–25 mg / day

Frequency

1× daily

Cycle length

4–6 weeks

Started only once the last ester has cleared — use the PCT timeline to place it. Beginning while active substance still circulates wastes the attempt.

Secondary hypogonadism (off-label)

Medical

Dose

12.5–25 mg / day

Frequency

1× daily or every other day

Cycle length

Ongoing, medically supervised

Used off-label as an alternative to TRT when preserving fertility matters, since it raises the body's own production instead of replacing it.

Higher doses

Advanced

Dose

> 25 mg / day

Frequency

1× daily

Cycle length

The LH response saturates. More does not raise testosterone further but does increase side effects.

Supraphysiological doses carry significant health risks and are not legal without a medical indication. This information serves education and harm reduction, not as a usage recommendation. Accompanying blood work and — where relevant — a post-cycle plan (PCT) are essential. See the disclaimer.

Side effect & countermeasure

Typical problems and what you can do to reduce harm — at a glance. Does not replace medical monitoring.

Problem

Rising estradiol as testosterone increases

Countermeasure

More of the body's own testosterone means more substrate for aromatase. Measure estradiol alongside testosterone rather than only tracking the latter; an aromatase inhibitor is rarely needed here and should not be added preventively.

Problem

Mood changes, though milder than with clomiphene

Countermeasure

Enclomiphene lacks the zuclomiphene isomer responsible for most mood and visual side effects. If they still occur, reduce the dose — the effect on LH is already saturated at low doses.

Problem

Started too early after the cycle

Countermeasure

As long as exogenous substance is still circulating, the axis cannot restart. With long esters that means weeks of waiting. Place the start using the ester half-life calculator rather than by the calendar.

Problem

Expecting it to replace a full recovery plan

Countermeasure

Enclomiphene raises LH and FSH but does not repair a testicular apparatus that has been inactive for months. HCG before the recovery phase prepares the testes; the SERM restarts the signal from above.

Problem

Uncertain product quality

Countermeasure

No approved pharmaceutical product exists. Only sources with an independent analysis certificate; underdosed and mislabelled products are common.

Overview

Enclomiphene is one half of clomiphene. Clomiphene as sold is a mixture of two isomers — enclomiphene and zuclomiphene — that behave very differently. Enclomiphene produces the desired effect on the hormonal axis; zuclomiphene is largely responsible for the mood changes and visual disturbances clomiphene is known for, and it stays in the body far longer.

Separating the two is the entire point of this substance. What remains is the effect without most of the baggage.

Mechanism of Action

The hypothalamus measures estrogen levels to decide how much GnRH to release, which in turn determines LH and FSH from the pituitary and ultimately testosterone production in the testes.

Enclomiphene blocks the estrogen receptor at the hypothalamus. The body therefore reads a low estrogen level, concludes that testosterone is insufficient, and increases the signal. LH and FSH rise, and the testes produce more testosterone.

The key distinction from testosterone replacement is that this raises the body's own production rather than supplying hormone from outside. Fertility is preserved, and the axis is not suppressed — which is exactly why it is used after a cycle and as an alternative to TRT in some cases.

Zuclomiphene, the isomer that is absent here, has a half-life measured in days to weeks and accumulates over a course of treatment. That accumulation is the reason clomiphene's side effects often only appear after two or three weeks.

Typical Context

The main application is restarting the axis after a cycle, over four to six weeks at twelve and a half to twenty-five milligrams a day.

Timing determines whether it works at all. As long as exogenous testosterone is still circulating, the hypothalamus continues to read a sufficient level, and no SERM changes that. With a long ester this means several weeks of waiting after the last injection — starting earlier does not accelerate recovery, it wastes the attempt.

A second point is regularly misunderstood. Enclomiphene restarts the signal from above, but it cannot do anything about testes that have been inactive for months and respond poorly. This is the reason HCG is used before the recovery phase rather than during it: first restore the responsiveness of the organ, then restart the signal.

Off-label it is also used as an alternative to TRT, particularly where fertility matters — since replacement therapy suppresses sperm production while enclomiphene does not.

Side Effects & Risks

  • Rising estradiol as the body's own testosterone increases
  • Mood changes, milder than with clomiphene but possible
  • Headache, nausea
  • Visual disturbances — rare here, unlike with clomiphene
  • No approved pharmaceutical product; quality varies

Blood Work & Monitoring

  • LH and FSH — whether the signal is actually rising; the direct measure of effect
  • Total/free testosterone — the result of that signal
  • Estradiol (sensitive) — rises along with testosterone
  • Liver values (ALT, AST, GGT) — as a baseline

Harm-Reduction Notes

  • Place the start using the ester half-life calculator, not by the calendar
  • Measure estradiol alongside testosterone; do not add an aromatase inhibitor preventively
  • Low doses are sufficient — the LH response saturates early
  • Not a substitute for a complete recovery plan; HCG belongs before it, not alongside
  • Only sources with an independent analysis certificate
  • Persistent mood changes are a reason to reduce the dose, not to push through

Legal status by region

Regulation differs considerably between jurisdictions and changes over time. This is a rough orientation, not legal advice — check the rules that apply where you are.

RegionRegulatory status
United StatesNot approved for human useSold as a research chemical; marketing for human consumption is unlawful.
EU / UKNo marketing authorisationNeither a medicine nor a supplement — no legal route for human use.
Most other jurisdictionsUnregulated grey areaPossession is legal in many places precisely because no framework covers it. That is not an indication of safety.
Competitive sportProhibitedListed by WADA where a relevant class applies.
All content on this page is for information and harm-reduction purposes only. It is not medical advice, not a recommendation to purchase or use, and does not replace consulting a doctor. Legal status and enforcement vary by country and change; verifying the current rules in your own jurisdiction is your responsibility. For adults 18+ only. See the full disclaimer.